Sling Therapeutics

Ann Arbor, United States

Sling Therapeutics is a biopharmaceutical company focused on late-stage development for thyroid eye disease.

Jun 2022

Series A

Biopharma Biotechnology

Top Investors

The Rise Fund

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Sling Therapeutics

Who are Sling Therapeutics's investors?

Sling Therapeutics's investors include The Rise Fund.

Where is Sling Therapeutics headquartered?

Sling Therapeutics is headquartered in Ann Arbor, United States.

What does Sling Therapeutics do?

Sling Therapeutics is a biopharmaceutical company focused on late-stage development for thyroid eye disease.

What stage is Sling Therapeutics at?

Sling Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 13, 2022.

MLA

"Sling Therapeutics — Funding & Investors." VCBacked, June 13, 2022, https://www.vcbacked.co/company/sling-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2022). Sling Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/sling-therapeutics

Wikipedia (cite web)

{{cite web |title=Sling Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/sling-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 13, 2022.

Similar Companies in Biopharma

View all

Living In Silico Inc.

San Francisco$3000.0M

EGenesis

Cambridge$191.0M

Crystalys Therapeutics

San Diego$205.0M

ReCode Therapeutics

Dallas$29.4M